We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Community Health Systems (CYH) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Community Health Systems (CYH - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
Community Health Systems is a member of the Medical sector. This group includes 1160 individual stocks and currently holds a Zacks Sector Rank of #7. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Community Health Systems is currently sporting a Zacks Rank of #1 (Strong Buy).
The Zacks Consensus Estimate for CYH's full-year earnings has moved 28.3% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that CYH has returned about 2.6% since the start of the calendar year. Meanwhile, the Medical sector has returned an average of -16.5% on a year-to-date basis. This means that Community Health Systems is performing better than its sector in terms of year-to-date returns.
Another stock in the Medical sector, LumiraDx Limited , has outperformed the sector so far this year. The stock's year-to-date return is 9.2%.
For LumiraDx Limited, the consensus EPS estimate for the current year has increased 6% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Community Health Systems belongs to the Medical - Hospital industry, a group that includes 6 individual companies and currently sits at #109 in the Zacks Industry Rank. On average, stocks in this group have gained 34.5% this year, meaning that CYH is slightly underperforming its industry in terms of year-to-date returns.
In contrast, LumiraDx Limited falls under the Medical Services industry. Currently, this industry has 61 stocks and is ranked #190. Since the beginning of the year, the industry has moved -56.5%.
Going forward, investors interested in Medical stocks should continue to pay close attention to Community Health Systems and LumiraDx Limited as they could maintain their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is Community Health Systems (CYH) Outperforming Other Medical Stocks This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Community Health Systems (CYH - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
Community Health Systems is a member of the Medical sector. This group includes 1160 individual stocks and currently holds a Zacks Sector Rank of #7. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Community Health Systems is currently sporting a Zacks Rank of #1 (Strong Buy).
The Zacks Consensus Estimate for CYH's full-year earnings has moved 28.3% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that CYH has returned about 2.6% since the start of the calendar year. Meanwhile, the Medical sector has returned an average of -16.5% on a year-to-date basis. This means that Community Health Systems is performing better than its sector in terms of year-to-date returns.
Another stock in the Medical sector, LumiraDx Limited , has outperformed the sector so far this year. The stock's year-to-date return is 9.2%.
For LumiraDx Limited, the consensus EPS estimate for the current year has increased 6% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Community Health Systems belongs to the Medical - Hospital industry, a group that includes 6 individual companies and currently sits at #109 in the Zacks Industry Rank. On average, stocks in this group have gained 34.5% this year, meaning that CYH is slightly underperforming its industry in terms of year-to-date returns.
In contrast, LumiraDx Limited falls under the Medical Services industry. Currently, this industry has 61 stocks and is ranked #190. Since the beginning of the year, the industry has moved -56.5%.
Going forward, investors interested in Medical stocks should continue to pay close attention to Community Health Systems and LumiraDx Limited as they could maintain their solid performance.